SCHEMBL6776450

SCHEMBL6776450

CC(C)c1cc(O)c2c3c(C(N)=O)cccc3n(Cc3cccc(F)c3)c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.39
GLA P06280 1/20 0.39
F10 P00742 3/20 0.39
PLA2G2A P14555 2/20 0.38
POLB P06746 1/20 0.37
IDO1 P14902 1/20 0.37
TSHR P16473 2/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
ALOX15 P16050 1/20 0.37
CYP2C19 P33261 1/20 0.37
MAPK8 P45983 1/20 0.37
ALOX5AP P20292 1/20 0.37
FABP3 P05413 1/20 0.36
FEN1 P39748 1/20 0.36
HTT P42858 1/20 0.35
FABP4 P15090 1/20 0.35
CASR P41180 1/20 0.35
GAA P10253 1/20 0.35
SCD O00767 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6689186 0.90 PLA2G2A (0.46) PLA2G2ACASR
SCHEMBL6775864 0.89 ADRA1D (0.41) F10PLA2G2ATSHRMAPK8FEN1
SCHEMBL6895034 0.88 L3MBTL1 (0.43) LMNAGLAF10POLBIDO1
SCHEMBL6775770 0.88 F10 (0.39) LMNAF10PLA2G2APOLBMAPK8
SCHEMBL6771712 0.88 PLA2G2A (0.51) F10PLA2G2ACYP2D6CYP2C9CYP2C19
SCHEMBL6776586 0.87 MAPT (0.42) LMNAF10POLBMAPK8FEN1
SCHEMBL6780031 0.87 PLA2G2A (0.44) F10PLA2G2ACASR
SCHEMBL6774350 0.87 PLA2G2A (0.40) F10PLA2G2A
SCHEMBL6688565 0.87 LMNA (0.43) LMNAGLAF10PLA2G2APOLB
SCHEMBL6691129 0.86 F10 (0.46) LMNAGLAF10PLA2G2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6713645-B1 INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK ELI LILLY AND COMPANY 2004-03-30 US disclosed
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP disclosed